BidaskClub cut shares of Lantheus (NASDAQ:LNTH) from a hold rating to a sell rating in a report published on Friday.
Several other analysts have also commented on LNTH. ValuEngine lowered Lantheus from a buy rating to a hold rating in a report on Friday, December 1st. Zacks Investment Research lowered Lantheus from a hold rating to a strong sell rating in a report on Friday, March 2nd. Two equities research analysts have rated the stock with a sell rating, one has assigned a hold rating and four have issued a buy rating to the company’s stock. The company has an average rating of Hold and a consensus price target of $24.75.
Lantheus (NASDAQ:LNTH) opened at $16.80 on Friday. The company has a current ratio of 3.16, a quick ratio of 2.60 and a debt-to-equity ratio of 11.40. The firm has a market capitalization of $630.10 and a P/E ratio of 17.14. Lantheus has a 12-month low of $10.65 and a 12-month high of $24.45.
In other Lantheus news, insider Michael P. Duffy sold 21,655 shares of the firm’s stock in a transaction that occurred on Wednesday, January 10th. The stock was sold at an average price of $22.40, for a total value of $485,072.00. Following the sale, the insider now directly owns 156,784 shares of the company’s stock, valued at $3,511,961.60. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, SVP Timothy G. Healey sold 3,696 shares of the firm’s stock in a transaction that occurred on Monday, February 26th. The shares were sold at an average price of $19.58, for a total value of $72,367.68. Following the completion of the sale, the senior vice president now directly owns 64,582 shares in the company, valued at $1,264,515.56. The disclosure for this sale can be found here. Over the last three months, insiders sold 29,217 shares of company stock worth $648,368. 2.30% of the stock is owned by corporate insiders.
A number of institutional investors and hedge funds have recently modified their holdings of LNTH. Vanguard Group Inc. grew its holdings in Lantheus by 87.5% in the second quarter. Vanguard Group Inc. now owns 1,478,350 shares of the medical equipment provider’s stock valued at $26,093,000 after purchasing an additional 689,954 shares during the period. State Street Corp boosted its stake in shares of Lantheus by 3,932.8% in the second quarter. State Street Corp now owns 617,014 shares of the medical equipment provider’s stock worth $10,891,000 after acquiring an additional 601,714 shares during the last quarter. Dimensional Fund Advisors LP boosted its stake in shares of Lantheus by 73.7% in the third quarter. Dimensional Fund Advisors LP now owns 911,311 shares of the medical equipment provider’s stock worth $16,221,000 after acquiring an additional 386,771 shares during the last quarter. LSV Asset Management boosted its stake in shares of Lantheus by 57.5% in the fourth quarter. LSV Asset Management now owns 953,906 shares of the medical equipment provider’s stock worth $19,507,000 after acquiring an additional 348,298 shares during the last quarter. Finally, Arrowstreet Capital Limited Partnership acquired a new stake in shares of Lantheus in the fourth quarter worth approximately $6,552,000. 90.46% of the stock is currently owned by institutional investors.
COPYRIGHT VIOLATION WARNING: This piece of content was originally posted by Sports Perspectives and is the property of of Sports Perspectives. If you are accessing this piece of content on another site, it was illegally stolen and republished in violation of US & international copyright & trademark law. The legal version of this piece of content can be read at https://sportsperspectives.com/2018/03/13/lantheus-lnth-downgraded-by-bidaskclub-to-sell.html.
Lantheus Holdings, Inc is engaged in the development, manufacture and commercialization of diagnostic medical imaging agents and products that assist clinicians in the diagnosis and treatment of cardiovascular and other diseases. Its imaging agents and products are used across a range of imaging modalities, including echocardiography and nuclear imaging.
Receive News & Ratings for Lantheus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lantheus and related companies with MarketBeat.com's FREE daily email newsletter.